IL10 and type 1 diabetes mellitus: Taken together, these findings could support the hypothesis that several regulatory mechanisms, in particular those acting via IL-27 and IL-10, attempt unsuccessfully to dampen the harmful effects of Th17 immunity in T1D patients.